Kaufmann Sascha, Schulze Maximilian, Horger Thomas, Oelker Aenne, Nikolaou Konstantin, Horger Marius
Department of Diagnostic and Interventional Radiology, Eberhard Karls University, Hoppe-Seyler-St 3, 72076 Tübingen, Germany.
Department of Diagnostic and Interventional Radiology, Eberhard Karls University, Hoppe-Seyler-St 3, 72076 Tübingen, Germany.
Acad Radiol. 2015 Sep;22(9):1099-105. doi: 10.1016/j.acra.2015.04.005. Epub 2015 Jun 23.
To assess the reproducibility of volume computed tomographic perfusion (VPCT) measurements in normal pancreatic tissue using two different kinetic perfusion calculation models at three different time points.
Institutional ethical board approval was obtained for retrospective analysis of pancreas perfusion data sets generated by our prospective study for liver response monitoring to local therapy in patients experiencing unresectable hepatocellular carcinoma, which was approved by the institutional review board. VPCT of the entire pancreas was performed in 41 patients (mean age, 64.8 years) using 26 consecutive volume measurements and intravenous injection of 50 mL of iodinated contrast at a flow rate of 5 mL/s. Blood volume(BV) and blood flow (BF) were calculated using two mathematical methods: maximum slope + Patlak analysis versus deconvolution method. Pancreas perfusion was calculated using two volume of interests. Median interval between the first and the second VPCT was 2 days and between the second and the third VPCT 82 days. Variability was assessed with within-patient coefficients of variation (CVs) and Bland-Altman analyses. Interobserver agreement for all perfusion parameters was calculated using intraclass correlation coefficients (ICCs).
BF and BV values varied widely by method of analysis as did within-patient CVs for BF and BV at the second versus the first VPCT by 22.4%/50.4% (method 1) and 24.6%/24.0% (method 2) measured in the pancreatic head and 18.4%/62.6% (method 1) and 23.8%/28.1% (method 2) measured in the pancreatic corpus and at the third versus the first VPCT by 21.7%/61.8% (method 1) and 25.7%/34.5% (method 2) measured also in the pancreatic head and 19.1%/66.1% (method 1) and 22.0%/31.8% (method 2) measured in the pancreatic corpus, respectively. Interobserver agreement measured with ICC shows fair-to-good reproducibility.
VPCT performed with the presented examinational protocol is reproducible and can be used for monitoring purposes. Best reproducibility was obtained with both methods for BF and with method 2 also for BV data for both follow-up studies.
使用两种不同的动态灌注计算模型,在三个不同时间点评估正常胰腺组织中容积计算机断层扫描灌注(VPCT)测量的可重复性。
对我们前瞻性研究中生成的胰腺灌注数据集进行回顾性分析,该研究旨在监测不可切除肝细胞癌患者局部治疗后的肝脏反应,已获得机构伦理委员会批准,且该前瞻性研究已获机构审查委员会批准。对41例患者(平均年龄64.8岁)的整个胰腺进行VPCT检查,连续进行26次容积测量,并以5 mL/s的流速静脉注射50 mL碘化造影剂。使用两种数学方法计算血容量(BV)和血流量(BF):最大斜率+Patlak分析与去卷积法。使用两个感兴趣容积计算胰腺灌注。第一次和第二次VPCT之间的中位间隔为2天,第二次和第三次VPCT之间为82天。使用患者内变异系数(CV)和Bland-Altman分析评估变异性。使用组内相关系数(ICC)计算所有灌注参数的观察者间一致性。
BF和BV值因分析方法不同而有很大差异,第二次与第一次VPCT相比,胰腺头部BF和BV的患者内CV分别为22.4%/50.4%(方法1)和24.6%/24.0%(方法2),胰腺体部为18.4%/62.6%(方法1)和23.8%/28.1%(方法2);第三次与第一次VPCT相比,胰腺头部BF和BV的患者内CV分别为21.7%/61.8%(方法1)和25.7%/34.5%(方法2),胰腺体部为19.1%/66.1%(方法1)和22.0%/31.8%(方法2)。用ICC测量的观察者间一致性显示出良好到较好的可重复性。
按照所介绍的检查方案进行的VPCT具有可重复性,可用于监测目的。在两项随访研究中,两种方法对BF以及方法2对BV数据均获得了最佳可重复性。